Affordable Access

Publisher Website

Inhibition of FGF-2-Mediated Chemotaxis of Murine Brain Capillary Endothelial Cells by Cyclic RGDfV Peptide through Blocking the Redistribution of c-Src into Focal Adhesions

Experimental Cell Research
Publication Date
DOI: 10.1006/excr.2001.5276
  • Fgf-2
  • Crgdfv Peptide
  • αVβ3Integrin
  • Endothelial Cells
  • Motility
  • C-Src
  • Biology


Abstract The α vβ 3 integrin is essential for fibroblast growth factor (FGF)-induced angiogenesis in vivo. However, the role of this integrin in FGF-2-mediated cellular responses by cultured endothelial cells is largely unknown. Cyclic RGDfV (cRGDfV) peptide is widely used to inhibit the binding of α vβ 3 integrin to vitronectin. To investigate the role of this integrin in FGF-2-mediated cellular responses, we used immortalized murine brain capillary endothelial cells, denoted IBE cells. Because IBE cells proliferate and migrate in response to FGF-2-treatment, when cultured on fibronectin-coated surface, we first examined the inhibitory activity of this peptide on the binding of α vβ 3 integrin to fibronectin as well as vitronectin. Solid phase binding assay revealed that cRGDfV peptide strongly inhibited the binding of purified α vβ 3 integrin to vitonectin- and fibronectin-coated plastic surfaces at a concentration of 50 μM. cRGDfV peptide at 50 μM inhibited spreading as well as adhesion of IBE cells on vitronectin-coated plastic surface but not on fibronectin. On fibronectin-coated substrata, cRGDfV at 50 μM attenuated FGF-2-mediated chemotaxis, but not FGF-2-induced proliferation, of IBE cells. We have previously demonstrated that mitogen-activated protein kinase (MAPK) activation within focal adhesions through c-Src activity was involved in FGF-2-induced chemotaxis of IBE cells. Treatment of cells with cRGDfV peptide was associated with reduced c-Src activity without tyrosine dephosphorylation. Immunofluorescent staining showed that cRGDfV inhibited redistribution of c-Src into focal adhesions. MAPK activation by FGF-2 within focal adhesions was also attenuated in the presence of cRGDfV peptide. Our results indicated that cRGDfV peptide inhibited redistribution of c-Src into focal adhesions, leading to impaired MAPK activation within focal adhesions and motility in FGF-2-treated endothelial cells.

There are no comments yet on this publication. Be the first to share your thoughts.